Using GDF15-transgenic mice, Kim et al. suggested that increased GDF15 acts as a compensatory mechanism to limit the progression of MASLD (Kim et al. 2018). This evidence concerns the gene GDF15 and metabolic dysfunction-associated steatotic liver disease.